Estrogen patch

Vivelle-dot, an estrogen patch

The estrogen patch (oestrogen patch) is a delivery system for estradiol, which is used as hormone replacement therapy to treat the problems of menopause, such as hot flashes and vaginal dryness, or to prevent osteoporosis. They are also used in hormone replacement therapy for male to female transgender people. The estrogen is given transdermally rather than via oral tablets, meaning that the estrogen patch carries similar risks and benefits that conventional forms of estrogen-only hormone replacement therapy have, but there are also important differences.

The route of administration of estrogens may have implications for adverse effects. For example, transdermal estrogen bypasses the liver so avoids the liver effects that occur with use of oral medications, and has slightly different effects on triglycerides and cholesterol than oral estrogens. Also, the specific type of estrogen is of importance, with transdermal 17-beta estradiol not having the increased risk of venous thromboembolism seen with ethinyl estradiol.

Administration

Applied twice weekly or weekly, depending on the brand, to fatty areas of the skin which crease less, preferably the lower abdomen or buttocks. Never to the breasts.

Brand names

"Evorel patch" redirects here. For the brand of patch containing ethinyl estradiol and norelgestromin, see Evra patch.

Patches with progestogens

Some patch systems for hormone replacement therapy consist of a continuous estrogen patch in addition to an intermittent patch containing a progestogen (progestin), in order to decrease disturbances in the endometrium of the uterus. The combination of estrogen and progestogen make them somewhat similar to the contraceptive patch. For example, Sequidot consists of a continuous estradiol patch in addition to a norethisterone patch that is worn 14 days in each 28 day cycle.[1]

References

  1. ↑ Drugs.com > Sequidot. Retrieved March 2014

External links


This article is issued from Wikipedia - version of the Friday, August 21, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.